To include your compound in the COVID-19 Resource Center, submit it here.

Pfizer's palbociclib gets breakthrough designation

Pfizer Inc. (NYSE:PFE) said FDA granted breakthrough drug designation to palbociclib ( PD-0332991) to treat breast

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE